anemia induced by ulcers and /or erosions of small intestine
Conditions
Interventions
rebamipide 900mg/day
Sponsors
Dept of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age: more than 20 years old. Regardless of sex. 2. Patients who were diagnosed as iron deficiency anemia and /or occult blood test of feces positive 3. Patients whose LDAs and/or NSAIDs and/or other anti-platelet agents doses were not changed in 3 months before informed consent acquisition. 4. Patients who were not detected any lesions speculated to be the cause of anemia in GIF and CF examination in 3 months before informed consent acquisition. 5. Patient whose informed consent was obtained in the documents.
Exclusion criteria
Exclusion criteria: 1.Patients who were detected some bleeding lesions in GI tract. 2.Patients who were diagnosed as GI tract obstraction. 3.Patients with malignant neoplasia 4.Patients who were detected any tumors and /or diverticula as the origin of bleeding in small intestine. 5.Patients who were speculated to have bleeding from the diverticulum of colon. 6.Patinets of Crohn' s disease and/or UC. 7.Patients who were speculated to the bleeding from anywhere but GI tract. 8.Patient who received surgical operation in 3 months before study. 9.Patients whose medication were changed. 10.Patients who undergo dialysis. 11.Patients who have renal disturbance; serum creatinine, Scr>2 mg/dL. 12. Patients who need erythropoietin administration 13. Patients who were speculated to be iron uptake disturbance after gastrectomy 14. Patients who are decompensated liver cirrhosis 15. Patients who take sulfasalazine and/or misoprostole and/or antibiotics 16. Patients who are judged to be inappropriate for this clinical trial by attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| changes of hemoglobin by rebamipide treatment | — |
Countries
Japan
Contacts
Public ContactKataoka H, Kubota E
Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan Dept of Gastroenterology and Metabolism
Outcome results
None listed